Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient.
With the broad employment of immunosuppressive therapy, the incidence of Pseudallescheria boydii infections is rising. We report a first case of the localized subcutaneous P. boydii infection in a patient with microscopic polyangiitis. Favorable outcome related to the treatment with voriconazole adds to the growing body of evidence supporting the use of this particular agent in P. boydii infections.
Lainscak
Mitja
M
Department of Internal Medicine, General Hospital Murska Sobota, 9000, Murska Sobota, Slovenia. mitja.lainscak@guest.arnes.si
Hocevar
Alojzija
A
Logar
Dusan
D
Beović
Bojana
B
Matos
Tadeja
T
Tomsic
Matija
M
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D008271:Mycetoma / Q000276:immunology*; D011541:Pseudallescheria / Q000276:immunology* / Q000472:pathogenicity; D014657:Vasculitis / Q000188:drug therapy / Q000382:microbiology
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone